过氧化物酶体增殖物激活受体、共激活因子及下游靶点。
Peroxisome proliferator-activated receptors, coactivators, and downstream targets.
作者信息
Qi C, Zhu Y, Reddy J K
机构信息
Department of Pathology, Northwestern University Medical School, Chicago, Illinois 60611, USA.
出版信息
Cell Biochem Biophys. 2000;32 Spring:187-204. doi: 10.1385/cbb:32:1-3:187.
Peroxisomes in liver parenchymal cells proliferate in response to structurally diverse nonmutagenic compounds designated as peroxisome proliferators (PP). Sustained induction of peroxisome proliferation and peroxisomal fatty acid beta-oxidation system in rats and mice leads to the development of liver tumors. Two mechanistic issues are important for consideration: elucidation of the upstream events responsible for the tissue and species specific induction of the characteristic pleiotropic responses by PPs; and delineation of the downstream events associated with peroxisome proliferation, and their role in the development of liver tumors in species that are sensitive to the induction of peroxisome proliferation. The induction of peroxisome proliferation is mediated by PP-activated receptor alpha (PPAR alpha), a member of a group of transcription factors that regulate the expression of genes associated with lipid metabolism and adipocyte differentiation. Three isotypes of this family of nuclear receptors, namely PPAR alpha, PPAR gamma, and PPAR delta (also called beta), have been identified as products of separate genes. Although PPAR alpha is responsible for the PP-induced pleiotropic responses, PPAR gamma seems to be involved in adipogenesis and differentiation, but the events associated with PPAR gamma do not directly involve peroxisomes and peroxisome proliferation. PPARs heterodimerize with 9-cis retinoic acid receptor (RXR), and bind to PP response element(s) (PPREs) on the target gene promoter to initiate inducible transcriptional activity. Tissue and species responses to PPs depend on pharmacokinetics, relative abundance of PPAR isotypes, nature of PPRE in the upstream regions of target genes, the extent of competition or cross-talk among nuclear transcription factors for PPAR heterodimerization partner retinoid X receptor and the modulating role of coactivators and corepressors on ligand-dependent transcription of PPARs. Using PPAR as bait in the yeast two-hybrid system, the authors recently cloned mouse steroid receptor coactivator-1 (SRC-1) and PPAR-binding protein (PBP), and identified them as PPAR coactivators. Both SRC-1 and PBP contain LXXLL signature motifs, considered necessary and sufficient for the binding of coactivators to nuclear receptors. A multifaceted approach, which includes the identification of additional coactivators that may be responsible for cell specific transcriptional activation of PPAR-mediated target genes, and generation of genetically modified animals (transgenic and gene disrupted), will be necessary to gain more insight into the upstream and downstream targets responsible for the induction of early and delayed PP-induced pleiotropic responses. In this context, it is important to note that mice deficient in fatty acyl-CoA oxidase, the first and rate-limiting enzyme of the peroxisomal beta-oxidation system, revealed that this enzyme is indispensable for the physiological regulation of PPAR alpha, and the absence of this enzyme leads to sustained transcriptional activation of genes regulated by this receptor.
肝实质细胞中的过氧化物酶体可响应多种结构各异的非诱变化合物(称为过氧化物酶体增殖剂,PP)而增殖。大鼠和小鼠体内过氧化物酶体增殖及过氧化物酶体脂肪酸β-氧化系统的持续诱导会导致肝肿瘤的发生。有两个机制问题值得考虑:阐明负责PP对组织和物种特异性诱导特征性多效性反应的上游事件;以及描绘与过氧化物酶体增殖相关的下游事件,及其在对过氧化物酶体增殖诱导敏感的物种肝肿瘤发生中的作用。过氧化物酶体增殖的诱导由PP激活受体α(PPARα)介导,PPARα是一组调节与脂质代谢和脂肪细胞分化相关基因表达的转录因子成员。该核受体家族的三种亚型,即PPARα、PPARγ和PPARδ(也称为β),已被鉴定为不同基因的产物。尽管PPARα负责PP诱导的多效性反应,但PPARγ似乎参与脂肪生成和分化,不过与PPARγ相关的事件并不直接涉及过氧化物酶体和过氧化物酶体增殖。PPAR与9-顺式视黄酸受体(RXR)形成异二聚体,并与靶基因启动子上的PP反应元件(PPRE)结合,以启动诱导型转录活性。组织和物种对PP的反应取决于药代动力学、PPAR亚型的相对丰度、靶基因上游区域PPRE的性质、核转录因子之间对PPAR异二聚体伴侣类视黄醇X受体的竞争或相互作用程度,以及共激活剂和共抑制因子对PPAR配体依赖性转录的调节作用。作者最近在酵母双杂交系统中以PPAR为诱饵,克隆了小鼠类固醇受体共激活剂-1(SRC-1)和PPAR结合蛋白(PBP),并将它们鉴定为PPAR共激活剂。SRC-1和PBP都含有LXXLL特征基序,被认为是共激活剂与核受体结合所必需且充分的。需要一种多方面的方法,包括鉴定可能负责PPAR介导的靶基因细胞特异性转录激活的其他共激活剂,以及生成转基因和基因敲除的基因修饰动物,以便更深入地了解负责早期和延迟PP诱导的多效性反应的上游和下游靶点。在此背景下,需要注意的是,缺乏过氧化物酶体β-氧化系统的第一种且限速酶——脂肪酰辅酶A氧化酶的小鼠表明,该酶对于PPARα的生理调节是不可或缺的,并且该酶的缺失会导致受该受体调节的基因持续转录激活。